Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy.
Goto A, Sukawa Y, Igarashi H, Onodera K, Aoki Y, Suzuki K, Yonezawa K, Yawata A, Kobayashi T, Kaneto H, Shimizu H, Wakasugi H, Matsunaga Y, Itoh M, Okuda H, Arimura Y, Shinomura Y. Goto A, et al. Among authors: igarashi h. Gan To Kagaku Ryoho. 2011 Sep;38(9):1461-6. Gan To Kagaku Ryoho. 2011. PMID: 21945893
HER2 expression and PI3K-Akt pathway alterations in gastric cancer.
Sukawa Y, Yamamoto H, Nosho K, Ito M, Igarashi H, Naito T, Mitsuhashi K, Matsunaga Y, Takahashi T, Mikami M, Adachi Y, Suzuki H, Shinomura Y. Sukawa Y, et al. Among authors: igarashi h. Digestion. 2014;89(1):12-7. doi: 10.1159/000356201. Epub 2014 Jan 20. Digestion. 2014. PMID: 24458107 Review.
Association of MicroRNA-31-5p with Clinical Efficacy of Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Igarashi H, Kurihara H, Mitsuhashi K, Ito M, Okuda H, Kanno S, Naito T, Yoshii S, Takahashi H, Kusumi T, Hasegawa T, Sukawa Y, Adachi Y, Okita K, Hirata K, Imamura Y, Baba Y, Imai K, Suzuki H, Yamamoto H, Nosho K, Shinomura Y. Igarashi H, et al. Ann Surg Oncol. 2015 Aug;22(8):2640-8. doi: 10.1245/s10434-014-4264-7. Epub 2014 Dec 4. Ann Surg Oncol. 2015. PMID: 25472647
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Nosho K, Igarashi H, Nojima M, Ito M, Maruyama R, Yoshii S, Naito T, Sukawa Y, Mikami M, Sumioka W, Yamamoto E, Kurokawa S, Adachi Y, Takahashi H, Okuda H, Kusumi T, Hosokawa M, Fujita M, Hasegawa T, Okita K, Hirata K, Suzuki H, Yamamoto H, Shinomura Y. Nosho K, et al. Among authors: igarashi h. Carcinogenesis. 2014 Apr;35(4):776-83. doi: 10.1093/carcin/bgt374. Epub 2013 Nov 15. Carcinogenesis. 2014. PMID: 24242331
EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.
Yamamoto I, Nosho K, Kanno S, Igarashi H, Kurihara H, Ishigami K, Ishiguro K, Mitsuhashi K, Maruyama R, Koide H, Okuda H, Hasegawa T, Sukawa Y, Okita K, Takemasa I, Yamamoto H, Shinomura Y, Nakase H. Yamamoto I, et al. Among authors: igarashi h. Oncotarget. 2017 Mar 14;8(11):17810-17818. doi: 10.18632/oncotarget.14863. Oncotarget. 2017. PMID: 28147317 Free PMC article.
MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Ito M, et al. Among authors: igarashi h. Int J Cancer. 2014 Dec 1;135(11):2507-15. doi: 10.1002/ijc.28920. Epub 2014 Apr 30. Int J Cancer. 2014. PMID: 24752710
Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis.
Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, Tachibana M, Tanuma T, Maguchi H, Shinohara T, Hasegawa T, Imamura M, Kimura Y, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Mitsuhashi K, et al. Among authors: igarashi h. Oncotarget. 2015 Mar 30;6(9):7209-20. doi: 10.18632/oncotarget.3109. Oncotarget. 2015. PMID: 25797243 Free PMC article.
Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway.
Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, Yoshii S, Takenouchi T, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Ito M, et al. Among authors: igarashi h. Int J Cancer. 2015 Sep 15;137(6):1258-68. doi: 10.1002/ijc.29488. Epub 2015 Mar 13. Int J Cancer. 2015. PMID: 25703934
The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.
Kurihara H, Maruyama R, Ishiguro K, Kanno S, Yamamoto I, Ishigami K, Mitsuhashi K, Igarashi H, Ito M, Tanuma T, Sukawa Y, Okita K, Hasegawa T, Imai K, Yamamoto H, Shinomura Y, Nosho K. Kurihara H, et al. Among authors: igarashi h. Oncotarget. 2016 Mar 15;7(11):12704-17. doi: 10.18632/oncotarget.7260. Oncotarget. 2016. PMID: 26871294 Free PMC article.
992 results